Evidence map›Paper›PMID 34342142›Full record

ArticleBrain and behavior2021

Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder.

Annamari Sorri, Kaija Järventausta, Olli Kampman, Kai Lehtimäki, Minna Björkqvist, Kati Tuohimaa, Mari Hämäläinen, Eeva Moilanen, Esa Leinonen

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Annamari SorriDepartment of Psychiatry, Tampere University Hospital, Tampere, Finland.ORCID 0000-0002-3565-2805
Kaija JärventaustaDepartment of Psychiatry, Tampere University Hospital, Tampere, Finland.
Olli KampmanDepartment of Psychiatry, Tampere University Hospital, Tampere, Finland.
Kai LehtimäkiDepartment of Neurosurgery, Neurology and Rehabilitation, Tampere University Hospital, Tampere, Finland.
Minna BjörkqvistDepartment of Psychiatry, Tampere University Hospital, Tampere, Finland.
Kati TuohimaaDepartment of Psychiatry, Tampere University Hospital, Tampere, Finland.
Mari HämäläinenThe Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland.
Eeva MoilanenThe Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland.
Esa LeinonenDepartment of Psychiatry, Tampere University Hospital, Tampere, Finland.
Tampere University Hospital · FITampere University · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesVascular endothelial growth factor (VEGF) has been related to the etiology of major depressive disorder (MDD). The findings involving the effects of electroconvulsive therapy (ECT) on the VEGF levels have been conflicting. The aim was to examine the possible changes in the VEGF levels and their associations with clinical outcome in patients with MDD during ECT.

methodsThe study comprised 30 patients suffering from MDD. Their plasma VEGF levels were measured at baseline and 2 and 4 hr after the first, fifth, and last ECT session. The severity of depression was quantified by the Montgomery-Asberg Depression Rating Scale (MADRS).

resultsThe VEGF levels increased between the 2-hr and 4-hr measurements during the first (p = .003) and the fifth (p = .017) sessions. The baseline VEGF levels between individual ECT sessions remained unchanged during the ECT series. No correlations were found between the increased VEGF levels and the clinical outcome.

conclusionsElectroconvulsive therapy increased the VEGF levels repeatedly at the same time point in two different ECT sessions. These increases had no association with the response to ECT. Consequently, VEGF may act as a mediator in the mechanism of action of ECT.

Indexed as

Electroconvulsive TherapyMajor Depressive DisorderHumansTreatment OutcomeVascular Endothelial Growth Factor AVascular Endothelial Growth FactorsVascular Endothelial Growth Factor AVascular Endothelial Growth Factorselectroconvulsive therapymajor depressive disordervascular endothelial growth factor

Identifiers

PMID34342142
PMCPMC8413728
OpenAlexW3191091157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.